Identifying pain genes: Bottom-up and top-down approaches

Journal of Pain

Volumn 1, Issue 3 SUPPL., 2000, Pages 66-80

  Mogil, Jeffrey S ^a   McCarson, Kenneth E ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Antisense; Gene expression; Gene mapping; Genetic; Transgenics

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; DNA;

CONFERENCE PAPER; GENE EXPRESSION; GENE MAPPING; GENETIC ANALYSIS; GENETIC LINKAGE; INTERMETHOD COMPARISON; KNOCKOUT GENE; NOCICEPTION; NONHUMAN; PAIN; TRANSGENIC ANIMAL;

EID: 0033830249     PISSN: 15265900     EISSN: None     Source Type: Journal    
DOI: 10.1054/jpai.2000.9821     Document Type: Conference Paper

References (152)

1. Transgenic mice
2. Altering the genome by homologous recombination
3. Proposed test battery and constellations of specific behavioral paradigms to investigate the behavioral phenotypes of transgenic and knockout mice
4. Transgenic studies of pain
5. Pain genes? Natural variation and transgenic mutants
6. Nociceptive and morphine antinociceptive sensitivity of 129 and C57BL/6 inbred mouse strains: Implications for transgenic knock-out studies
7. Gene-targeting studies: New methods, old problems
8. Gene-targeting studies of mammalian behavior: Is it the mutation or the background genotype?
9. Reverse piedpiperase: Is the knockout mouse leading neuroscientists to a watery end?
10. Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter
11. Deletion of a DNA polymerase β gene segment in T cells using cell type-specific gene targeting
12. Genetic variation among 129 substrains and its importance for targeted mutagenesis in mice
13. Locomotor activity in D2 dopamine receptor-deficient mice is determined by gene dosage genetic background and developmental adaptations
14. Genetic determinants of susceptibility to excitotoxic cell death: Implications for gene targeting approaches
15. Hot and cold nociception are genetically correlated
16. Heritability of nociception. I. Responses of eleven inbred mouse strains on twelve measures of nociception
17. Sex differences in supraspinal morphine analgesia are dependent on genotype
18. The influence of a targeted deletion of the IFNγ gene on emotional behaviors
19. Modulation of disease severity in cystic fibrosis transmembrane conductance regulator deficient mice by a secondary genetic factor
20. Targeted disruption of mouse EGF receptor: Effect of genetic background on mutant phenotype
21. Absence of opioid stress-induced analgesia in mice lacking β-endorphin by site-directed mutagenesis
22. Application of antisense DNA method for the study of molecular bases of brain function and behavior
23. Mapping of opioid receptors using antisense oligodeoxynucleotides: Correlating their molecular biology and pharmacology
24. Antisense oligonucleotides in psychopharmacology and behaviour: Promises and pitfalls
25. Antisense oligonucleotide strategies in neuropharmacology
26. Inhibition of rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotides
27. Blockade of U50488H analgesia by antisense oligodeoxynucleotides to a κ opioid receptor
28. Blockade of morphine analgesia by an antisense oligodeoxynucleotide against the mu receptor
29. Selective loss of δ opioid analgesia and binding by antisense oligodeoxynucleotides to a δ opioid receptor
30. Identification and characterization of three new alternatively spliced μ-opioid receptor isoforms
31. Novel receptor mechanisms for heroin and morphine-6β-glucuronide analgesia
32. Antisense mapping of MOR-1 in rats: Distinguishing between morphine and morphine-6β-glucuronide antinociception
33. Antisense mapping the MOR-1 opioid receptor: Evidence for alternative splicing and a novel morphine-6β-glucuronide receptor
34. 3-related opioid receptor
35. Antisense mapping KOR-1: Evidence for multiple kappa analgesic mechanisms
36. Antisense mapping DOR-1 in mice: Further support for δ receptor subtypes
37. Retention of heroin and morphine-6β-glucuronide analgesia in a new line of mice lacking exon 1 of MOR-1
38. Spinal neurokinin NK1 receptor down-regulation and antinociception: Effects of spinal NK1 receptor antisense oligonucleotides and NK1 receptor occupancy
39. Method of detection of specific RNAs in agarose gels by transfer to diazobenzyloxymethyl-paper and hybridization with DNA probes
40. Measurement of apolipoprotein mRNA by DNA-excess solution hybridization with single-stranded probes
41. NK-1 and NK-3 type tachykinin receptor mRNA expression in rat spinal cord dorsal horn is increased during adjuvant or formalin-induced nociception
42. Central and peripheral expression of neurokinin-1 and neurokinin-3 receptor and substance P-encoding mRNAs: Peripheral regulation during formalin-induced inflammation and lack of neurokinin receptor expression in primary afferent sensory neurons
43. The formalin-induced expression of tachykinin peptide and neurokinin receptor messenger RNAs in rat sensory ganglia and spinal cord is modulated by opiate preadministration
44. The neurokinin-1 antagonist LY306740 blocks nociception-induced increases in dorsal horn neurokinin-1 receptor gene expression
45. Quantification of mRNA in discrete cell groups of the brain by in situ hybridization histochemistry
46. Inflammation-induced upregulation of NK1 receptor mRNA in dorsal horn neurones
47. Development of a high-volume in-situ mRNA hybridization assay for the quantitation of gene expression
48. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase
49. Quantitation of RNA using the polymerase chain reaction
50. Identifying changes in gene expression in the nervous system: mRNA differential display
51. Quantitative monitoring of gene expression patterns with a complimentary DNA microarray
52. Neuronal nitric oxide synthase mRNA upregulation in rat sensory neurons after spinal nerve ligation: Lack of a role in allodynia development
53. Autotomy following peripheral nerve lesions: Experimental anaesthesia dolorosa
54. Reduplication in mice
55. A genetic map of the mouse suitable for typing intraspecific crosses
56. Use of recombinant inbred strains to identify quantitative trait loci in psychopharmacology
57. Mapping Mendelian factors underlying quantitative traits using RFLP linkage maps
58. On the power of experimental designs for the detection of linkage between marker loci and quantitative loci in crosses between inbred lines
59. Genetic dissection of complex traits
60. Quantitative trait loci mapping of three loci controlling morphine preference using inbred mouse strains
61. Taking stock of complex trait genetics in mice
62. Pharmacogenetic variability in neuronal nicotinic receptor-mediated antinociception
63. Genetic dissection of complex traits: Guidelines for interpreting and reporting linkage results
64. Localization to proximal Chromosome 10 of a locus influencing morphine-induced analgesia in crosses derived from C57BL/6 and DBA/2 mouse strains
65. Pharmacogenetic evidence for the involvement of 5-hydroxytryptamine serotonin-1B receptors in the mediation of morphine antinociceptive sensitivity
66. 2-opioid receptors
67. Identification of a sex-specific quantitative trait locus mediating non-opioid stress-induced analgesia in female mice
68. Positional cloning of the mouse circadian clock gene
69. The genetic dissection of brain-behaviour relationships: An introduction to neurobehavioral genetics
70. Positional cloning moves from perditional to traditional
71. Single-tube genotyping without oligonucleotide probes
72. High-throughput single nucleotide polymorphism genotyping by fluorescent 5' exonuclease assay
73. Large-scale identification mapping and genotyping of single-nucleotide polymorphisms in the human genome
74. Aggressiveness hypoalgesia and high blood pressure in mice lacking the adenosine A(2a) receptor
75. Peripheral sensory nerve defects in apolipoprotein E knockout mice
76. Nociception and inflammatory hyperalgesia in B2 bradykinin receptor knockout mice
77. 1 receptor knockout mice
78. 1 receptor knockout mice
79. Endothelin B receptor modulates inflammatory pain and cutaneous inflammation
80. Targeted disruption of the murine galanin gene
81. 0
82. Absence of prostaglandin E2-induced hyperalgesia in NMDA receptor epsilon subunit knockout mice
83. Behavioural characterization and amounts of brain monoamines and their metabolites in mice lacking histamine H1 receptors
84. Reduced nociceptive behavior in islet amyloid polypeptide amylin knockout mice
85. Interferon-γ receptors in nociceptive pathways: Role in neuropathic pain-related behavior
86. Nociceptive responses in interleukin-6-deficient mice to peripheral inflammation and peripheral nerve section
87. Defect in synaptic vesicle precursor transport and neuronal cell death in KIF1A motor protein-deficient mice
88. Disruption of the mouse L1 gene leads to malformations of the nervous system
89. Opioid-related changes in nociceptive threshold and in tissue levels of enkephalins after target disruption of the gene for neutral endopeptidase EC 342411 in mice
90. Mice lackig nerve growth factor display perinatal loss of sensory and sympathetic neurons yet develop basal forebrain cholinergic neurons
91. Analysis of cutaneous sensory neurons in transgenic mice lacking the low affinity neurotrophin receptor p75
92. Targeted disruption of the orphanin FQ/nociceptin gene increases stress susceptibility and impairs stress adaptation in mice
93. Nociceptin/OFQ gene knockout reveals an antinociceptive role for the nociceptin/OFQ in the mouse
94. Effect of peripheral axotomy on dorsal root ganglion neuron phenotype and autotomy behavior in neuropeptide Y-deficient mice
95. Severe sensory neuropathies in mice carrying a disrupted Trk/NGF receptor gene
96. Disruption of the κ-opioid receptor gene in mice enhances sensitivity to chemical visceral pain impairs pharmacological actions of the selective κ-agonist U-50488H and attenuates morphine withdrawal
97. Opiate receptor knockout mice define μ receptor roles in endogenous nociceptive responses and morphine-induced analgesia
98. Loss of morphine-induced analgesia reward effect and withdrawal symptoms in mice lacking the μ-opioid-receptor gene
99. Pain responses anxiety and aggression in mice deficient in preproenkephalin
100. Preserved acute pain and reduced neuropathic pain in mice lacking PKCγ
101. A novel nociceptor signaling pathway revealed in protein kinase C epsilon mutant mice
102. Diminished inflammation and nociceptive pain with preservation of neuropathic pain in mice with a targeted mutation of the Type I regulatory subunit of cAMP-dependent protein kinase
103. Increased anxiety and impaired pain response in puromycin-sensitive aminopeptidase gene-deficient mice obtained by a mouse gene-trap method
104. Lack of tactile pain allodynia in lipocalin-type prostaglandin D synthase-deficient mice
105. Altered pain perception and inflammatory response in mice lacking prostacyclin receptor
106. The tetrodotoxin-resistant sodium channel SNS has a specialized function in pain pathways
107. Primary afferent tachykinins are required to experience moderate to intense pain
108. Hypoalgesia in mice with a targeted deletion of the tachykinin 1 gene
109. Altered nociception analgesia and aggression in mice lacking the receptor for substance P
110. C-fos antisense oligodeoxynucleotide increases formalin-induced nociception and regulates preprodynorphin expression
111. Intrathecally administered c-fos antisense oligodeoxynucleotide decreases formalin-induced nociceptive behavior in adult rats
112. Thalamic NMDA receptors modulate inflammation-produced hyperalgesia in the rat
113. 1 inhibits spinal nociceptive transmission
114. A tetrodotoxin-resistant sodium current mediates inflammatory pain in the rat
115. A comparison of the potential role of the tetrodotoxin-insensitive sodium channels PN3/SNS and NaN/SNS2 in rat models of chronic pain
116. 2-adrenergic receptor subtypes gene expression in rat dorsal root ganglion in an experimental model of neuropathic pain
117. Expression of mRNA for brain-derived neurotrophic factor in the dorsal root ganglion following peripheral inflammation
118. Increased expression of preprotachykinin calcitonin gene-related peptide but not vasoactive intestinal peptide messenger RNA in dorsal root ganglia during the development of adjuvant monoarthritis in the rat
119. Nociceptive regulation of GABA(B) receptor gene expression in sensory systems of the rat
120. Change in mRNAs for neuropeptides and the GABAA receptor in dorsal root ganglion neurons in a rat experimental neuropathic pain model
121. Expression of GAD mRNA in spinal cord neurons of normal and monoarthritic rats
122. Orofacial pain increases mRNA level for galanin in the trigeminal nucleus caudalis of the rat
123. Evidence for galanin receptors in primary sensory neurones and effect of axotomy and inflammation
124. Expression and regulation of galanin-R2 receptors in rat primary sensory neurons: Effect of axotomy and inflammation
125. Primary sensory neurons exhibit altered gene expression in a rat model of neuropathic pain
126. Glutamate receptor gene expression in spinal cord of arthritic rats
127. Prolonged noxious stimulation increases periaqueductal gray NMDA mRNA expression: A hybridization study using two different rat models for nociception
128. Enhanced expression of metabotropic glutamate receptor 3 messenger RNA in the rat spinal cord during ultraviolet irradiation induced peripheral inflammation
129. Attenuation of IGF-1 antinociceptive action and a reduction in spinal cord gene expression of its receptor in experimental diabetes
130. Increase of interleukin-6 mRNA in the spinal cord following peripheral nerve injury in the rat: Potential role of IL-6 in neuropathic pain
131. NGF involvement in pain induced by chronic constriction injury of the rat sciatic nerve
132. Neurotrophin receptor expression is induced in a subpopulation of trigeminal neurons that label by retrograde transport of NGF or fluoro-gold following tooth injury
133. Expression of nitric oxide synthase type II in the spinal cord under conditions producing thermal hyperalgesia
134. Gene for pain modulatory neuropeptide NPFF: Induction in spinal cord by noxious stimuli
135. Nociceptin gene expression in rat dorsal root ganglia induced by peripheral inflammation
136. Expression of neuropeptide Y and neuropeptide Y Y1 receptor mRNA in rat spinal cord and dorsal root ganglia following peripheral tissue inflammation
137. Expression of mRNAs encoding full-length and truncated trkB receptors in rat dorsal root ganglia and spinal cord following peripheral inflammation
138. Chronic pain increases brainstem proneurotensin/neuromedin-N mRNA expression: A hybridization-histochemical and immunohistochemical study using three different rat models for chronic nociception
139. Expression of mu- and kappa- but not delta-opioid receptor mRNAs is enhanced in the spinal dorsal horn of the arthritic rats
140. Preproenkephalin gene expression in the rat spinal cord after noxious stimuli
141. Gene expression and localization of opioid peptides in immune cells of inflamed tissue: Functional role in antinociception
142. Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain
143. Coincident induction of K rev-1/rap 1A rap 1B and H-ras mRNAs in the rat spinal cord by noxious stimulation
144. The sodium channel auxiliary subunits b1 and b2 are differentially expressed in the spinal cord of neuropathic rats
145. Plasticity of sodium channel expression in DRG neurons in the chronic constriction injury model of neuropathic pain
146. Regulation of expression of the sensory neuron-specific sodium channel SNS in inflammatory and neuropathic pain
147. Streptozotocin-induced diabetes is associated with altered expression of peptide-encoding mRNAs in rat sensory neurons
148. A noxious stimulus induces the preprotachykinin-A gene expression in the rat dorsal root ganglion: A quantitative study using in situ hybridization histochemistry
149. The role of VIP/PACAP receptor subtypes in spinal somatosensory processing in rats with an experimental peripheral mononeuropathy